James S. Redpath

Managing Director

Mr. Redpath is a Managing Director of the firm and focuses on clients in the healthcare industry. He has worked as a mergers and acquisitions and corporate finance professional since 1990. Mr. Redpath has been engaged in over 75 transactions totaling over $30 billion in value and has a varied transaction experience, including sell-side representation, buy-side advisory transactions, joint ventures, strategic partnerships, restructurings, leveraged buyouts and fairness opinions. Mr. Redpath has also advised clients in private equity, public equity and debt financings. 

Mr. Redpath’s healthcare services sector focus includes Provider Outsourcing and Information Technology, Alternate Site and Outpatient Providers, Physician Group Management, Hospitals and Senior Living Facilities, Payor Outsourcing and Specialty Managed Care, and Specialty Pharmacy / Distribution. In addition to healthcare services, Mr. Redpath has experience in healthcare products sectors including medical technology, large cap and specialty pharmaceuticals, and early stage life sciences. 

Prior to joining Cypress Associates, Mr. Redpath was Head of Corporate Finance for Ziegler Capital Markets. Prior to Ziegler, Mr. Redpath was Managing Director and Co-Head of Friedman, Billings, Ramsey & Co. Inc.’s Healthcare Investment Banking Group. Prior to FBR, Mr. Redpath managed the North American Healthcare M&A business at Deutsche Bank Securities, Inc. Prior to Deutsche Bank, he spent over six years as a senior healthcare M&A professional at Morgan Stanley & Co. Incorporated and at Wasserstein Perella & Co. Incorporated. Mr. Redpath began his career at Kidder, Peabody & Co. Incorporated after graduating from business school in 1990. 

Mr. Redpath graduated with a B.A. degree in Economics, Magna Cum Laude, from Colgate University and received his M.B.A. with an emphasis in Finance from Harvard Business School. He holds Series 7, 24 and 63 securities licenses.